Lunch & Learn

Using Multiplexed Multi-Omics to Study
Spatial Heterogeneity in Ovarian Cancer

Wednesday, Jan 23

11:30 AM – 12:30 PM CST
NH 437
Center for Health Sciences
1111 W 17th St., Tulsa, OK 74107

Complete Spatial Transcriptomics Solutions

Join us to learn how Complete Genomics DNBSEQ™ technology and Stereo-seq technology, unlock discovery capabilities for cancer research and beyond.

With improved capture efficiency, broad compatibility, and faster workflows, Stereo-seq v1.3 and Stereo-OMNI for FFPE samples allow scientists to obtain gene expression information in a spatial dimension, furthering the understanding of diseases and accelerating drug or therapy discovery.

Key Highlights:

Customer experience using DNBSEQ technology and STOmics for enabling unbiased mapping of the whole transcriptome at single-cell resolution
Discovery with ultra-HD resolution spatial whole transcriptome profiling via Stereo-seq technology
Using 3D-targeted and non-targeted multiplex multi-omics analyses for molecular, metabolic, and subcellular mapping of the tumor immune microenvironment

Speakers:

Yongfu Wang, Ph.D.

Sr. Manager, Field & Sales Support for STOmics
Complete Genomics

Sammy Ferri-Borgogno, Ph.D.

Assistant Professor
Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery
MD Anderson Cancer Center

Why Choose Stereo-seq for Your Spatial Transcriptomics?

Stereo-seq technology achieves TRUE single-cell resolution

Stereo-seq (SpaTial Enhanced Resolution Omics-sequencing) technology enables:

Unparalleled field-of-view and subcellular resolution.
Simultaneous transcriptome analysis at multiple levels: tissue-wide, cellular, subcellular, and molecular.

Learn more

spatial-transcriptomics-subcellular-resolution

Register Now!

LUNCH & LEARN | Webinar

First Name

Last Name

Phone/Mobile

Organization

Dropdown

Country

State

City